oxalicumone A

structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Mitochondrial Diseases (Mitochondrial Disease) 01/01/2018 - "Hepatocellular toxicity of oxalicumone A via oxidative stress injury and mitochondrial dysfunction in healthy human liver cells."
2.	Neoplasms (Cancer) 07/15/2016 - "Oxalicumone A (POA1), a novel dihydrothiophene-condensed sulfur chromone isolated from the marine fungus Penicillium oxalicum SCSGAF 0023, showed cytotoxicity against several cancer cells previously. "
3.	Leukemia 07/15/2016 - "Oxalicumone A, a new dihydrothiophene-condensed sulfur chromone induces apoptosis in leukemia cells through endoplasmic reticulum stress pathway."
4.	Carcinoma (Carcinomatosis) 01/01/2018 - "The marine‑derived oxalicumone A (POA) has been demonstrated as a potent anti‑tumor bioactive agent for a variety of human carcinoma, but to the best of our knowledge, remains to be evaluated in healthy liver cells. "